Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC DIM-C-pPhCO2Me | 151358-48-4 | 99.5% | 380.44 | 50 MG
SDP

Catalog No. 5000439369
Encompass_Preferred

DIM-C-pPhCO2Me is a nuclear receptor 4A1 (NR4A1) antagonist that induces apoptosis and decreases various proteins including PAX3-FOXO1A, N-Myc, Rassf4, MyoD1, Grem1, and DAPK1. It also reduces TXNDC5 and IDH1 expression, while inducing ER stress markers (CHOP, ATF4, and p-PERK). This compound inhibits renal cell carcinoma and breast cancer, and is useful in rhabdomyosarcoma research.

  • Induces apoptosis
  • Decreases PAX3-FOXO1A, N-Myc, Rassf4, MyoD1, Grem1, and DAPK1 proteins
  • Reduces TXNDC5 and IDH1 expression
  • Induces markers of ER stress
  • Inhibits renal cell carcinoma
  • Inhibits breast cancer
  • Useful in rhabdomyosarcoma research

Catalog No. 50-004-39369 Supplier Medchemexpress LLC Supplier No. HY11205650MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

DIM-C-pPhCO2Me is a nuclear receptor 4A1 (NR4A1) antagonist that induces apoptosis and decreases various proteins including PAX3-FOXO1A, N-Myc, Rassf4, MyoD1, Grem1, and DAPK1. It also reduces TXNDC5 and IDH1 expression, while inducing ER stress markers (CHOP, ATF4, and p-PERK). This compound inhibits renal cell carcinoma and breast cancer, and is useful in rhabdomyosarcoma research.

  • Induces apoptosis
  • Decreases PAX3-FOXO1A, N-Myc, Rassf4, MyoD1, Grem1, and DAPK1 proteins
  • Reduces TXNDC5 and IDH1 expression
  • Induces markers of ER stress
  • Inhibits renal cell carcinoma
  • Inhibits breast cancer
  • Useful in rhabdomyosarcoma research

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.